Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul J. Clancy currently holds 23,235 shares of BIOGEN INC. (BIIB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul J. Clancy has been a net seller of BIIB stock. They have purchased $0 and sold $49.9M worth of shares.
Paul J. Clancy's most recent insider trade was on Sep 30, 2025, when they sold 285 shares at $84.81 per share.
Paul J. Clancy serves as Executive at BIOGEN INC. (BIIB). They have executed 211 insider transactions totaling $49.9M over their tenure at the company.
Paul J. Clancy holds the position of Executive at BIOGEN INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Paul J. Clancy has shown a selling trading pattern, with $0 in total purchases and $49.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul J. Clancy was on Apr 25, 2017, when they sold $2.9M worth of BIIB shares. This transaction involved 9,892 shares at $290.00 per share.
Paul J. Clancy currently owns 23,235 shares of BIOGEN INC. (BIIB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul J. Clancy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul J. Clancy has 211 Form 4 filings on record as an insider at BIOGEN INC..
Set alerts for Paul J. Clancy and 40,000+ other insiders.